Research Grants 5 show all


$236.4K
2003

$537.7K
2004

$300K
2005

$100K
2006

Patents 143show all

  • 59
    A61K - Preparations for medical, dental, or toilet purposes
  • 48
    B82Y - Specific uses or applications of nanostructures
  • 38
    C12N - Microorganisms or enzymes
  • 30
    C08B - Polysaccharides
  • 30
    C08G - Macromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds
  • 20
    C12Y - Enzymes
  • 11
    A61L - Methods or apparatus for sterilising materials or objects in general
  • 4
    C07K - Peptides
  • 3
    C08F - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
  • 2
    C07D - Heterocyclic compounds

SEC Filings show all


188
8-K

45
10-Q

14
10-K

6
D

1
S-1

Contact Information

SEC Form D Funding Events

DateOfferedSoldType
2013-10-22$64,000,000$64,000,000Equity
2013-05-16$36,000,000$36,000,000Equity
2010-09-30Indefinite$0Option to Acquire
2010-01-29$3,222,896$3,222,896Equity, Option to Acquire
2009-08-13$2,760,000$2,760,000Equity, Option to Acquire
2008-02-04Unknown Unknown Other (Paper Filing)

Key Executives

  • Christopher Anzalone
    Executive Officer, Director
  • Robert Bruce Stewart
    Executive Officer, Director
  • Joseph Theodore Kingsley
    Executive Officer
  • Edward Frykman
    Director
  • Charles McKenney
    Director
  • LeRoy Rahn
    Director
  • Kenneth A. Myszkowski
    Executive Officer
  • Mauro Ferrari
    Director
  • Douglass Given
    Director
  • Michael S. Perry
    Director
  • Bruce Given
    Executive Officer